Not recruiting
Registered drug
Study on Methoxyflurane for Pain Relief in Adult Dental Emergencies
Registered drug
- Substances:Methoxyflurane
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Methoxyflurane
Find therapies in clinical trials near you – page 41
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
584 trials match your criteria
Not recruiting
Alopecia areata
Not recruitingInvestigational
Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
Investigational
- Disease:Alopecia areata
- Substances:Upadacitinib
Countries:France
France- Participants:0–17 years · 18–64 years
- Substances:Upadacitinib
Not recruiting
Myelofibrosis
Not recruitingRegistered drugNo placebo
Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
Registered drugNo placebo
- Disease:Myelofibrosis
- Substances:ALKYLATING AGENTSANTIMETABOLITES+1
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:ALKYLATING AGENTS
Not recruiting
Giant cell arteritis
Not recruitingRegistered drugNo placebo
Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
Registered drugNo placebo
- Disease:Giant cell arteritis
- Substances:Folic AcidMethotrexate+2
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Folic Acid
Not recruiting
Systemic lupus erythematosus
Not recruitingRegistered drug
Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
Registered drug
- Disease:Systemic lupus erythematosus
- Substances:Obinutuzumab
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Obinutuzumab
Not recruiting
Amyotrophic lateral sclerosis
Not recruitingRegistered drug
Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)
Registered drug
- Disease:Amyotrophic lateral sclerosis
- Substances:GlucoseH-L-Tryphophanyl-L-Seryl-Glycyl-L-Tryptophanyl-L-Seryl-L-Seryl-L-Cysteinyl-L-Seryl-L-Arginyl-L-Seryl-L-Cysteinyl-Glycyl-Oh (Disulfide Bond), Acetate Salt
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Glucose
Not recruiting
Idiopathic pulmonary fibrosis
Not recruitingInvestigational
Study on Axatilimab for Patients with Idiopathic Pulmonary Fibrosis
Investigational
- Disease:Idiopathic pulmonary fibrosis
- Substances:Axatilimab
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Axatilimab
Not recruiting
Anti-neutrophil cytoplasmic antibody positive vasculitis+1
Not recruitingRegistered drugNo placebo
Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease
Registered drugNo placebo
- Disease:Anti-neutrophil cytoplasmic antibody positive vasculitisEnd stage renal disease
- Substances:AzathioprinePrednisolone+3
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Azathioprine
Not recruiting
Idiopathic pulmonary fibrosis
Not recruitingRegistered drugNo placebo
Study on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease
Registered drugNo placebo
- Disease:Idiopathic pulmonary fibrosis
- Substances:NintedanibPirfenidone
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Nintedanib
Not recruiting
Hormone-refractory prostate cancer
Not recruitingRegistered drugNo placebo
Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
Registered drugNo placebo
- Disease:Hormone-refractory prostate cancer
- Substances:EnzalutamideMasofaniten
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Enzalutamide
Not recruiting
B-cell lymphoma+1
Not recruitingRegistered drugNo placebo
Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
Registered drugNo placebo
- Disease:B-cell lymphomaFollicular lymphoma
- Substances:CyclophosphamideEpcoritamab+8
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Cyclophosphamide
Not recruiting
Adenocarcinoma gastric+1
Not recruitingRegistered drug
Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
Registered drug
- Disease:Adenocarcinoma gastricOesophageal adenocarcinoma
- Substances:CapecitabineCisplatin+3
Countries:France
France- Participants:18–64 years · 65+ years
- Substances:Capecitabine